Sanofi is committed to providing a website that is accessible to the widest possible audience, regardless of ability, disability, race, cultural background, gender, or technological requirements. We are actively working to increase the accessibility and usability of our website and in doing so adhere to many of the available standards and guidelines.
This accessibility declaration applies to the site epi.info.sanofi .
The accessibility status of epi.info.sanofi varies across different sites deployed on the ePI platform. While most sites are partially conformant with Web Content Accessibility Guidelines (WCAG) 2.2 Level AA, the exact level of compliance depends on the specific implementation of each site.
epi.info.sanofi has been built using code compliant with W3C standards for HTML and CSS.
Technologies used for the creation of this website:
This website was tested with the following browsers:
The website has been audited manually based on Sanofi Accessibility Global Standards. Automated audits were conducted on this website using the following Web Developer extensions:
All the pages of the website have been tested.
No tests have been conducted using assistive technology yet.
We are continually seeking out solutions that will bring all areas of the site up to the same level of overall web accessibility. In the meantime, should you experience any difficulty in accessing certain features of the epi.info.sanofi website, please don’t hesitate to contact us at eproductinformation@sanofi.com.
The current accessibility statement has been published on 17/02/2025.